Retinol; Retinyl Acetate; Retinyl Palmitate
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
Retinol; Retinyl Acetate; Retinyl Palmitate은(는) 부속서 III에 등재되어 있으며 이 기록에 표시된 조건에서만 사용할 수 있습니다. 이 기록의 최대 농도: (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE.
이 항목 읽는 방법
Vitamin A in cosmetics became a restricted substance in 2024, with limits expressed as Retinol Equivalent, a mandatory label warning, and two different deadlines that mean different things.
- Body lotion: 0.05% Retinol Equivalent. Other leave-on and rinse-off products: 0.3% RE.
- The limit is a Retinol Equivalent, so retinol, retinyl acetate and retinyl palmitate are counted together, not separately.
- The label must read: 'Contains Vitamin A. Consider your daily intake before use'.
- 1 November 2025 stops non-compliant products being placed on the market; 1 May 2027 stops them being made available.
Regulation (EU) 2024/996 added this entry after the SCCS revisited its opinion on vitamin A. The reasoning is about total intake rather than about the product: vitamin A reaches the body from food and supplements as well as from what is applied to skin, and the limits are set with that whole picture in mind. That is also what the mandatory warning is for — it asks the reader to think about their daily intake, not about the cosmetic alone.
Two details in the wording do real work. The limits are Retinol Equivalent, which means retinol, retinyl acetate and retinyl palmitate are converted to a common basis and counted together; a formula using two of them is not entitled to the limit twice. And the two dates are not a grace period followed by a reminder. From 1 November 2025 a non-compliant product may not be placed on the Union market — that is the manufacturer or importer's first supply. From 1 May 2027 it may not be made available, which reaches stock already in a distributor's or retailer's hands.
Between those dates, a product made before the first deadline can lawfully still be sold. After the second, it cannot, wherever it sits in the chain.
대조 대상
기록 세부 정보
최대 농도
(a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
기타 제한 사항
From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 May 2027 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.
경고 문구
For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’.
INCI 용어집 명칭
Retinol; Retinyl Acetate; Retinyl Palmitate
화학명
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
규제 정보
주요 데이터
화학적 정체 및 특성

Retinol
All-trans-retinol is a retinol in which all four exocyclic double bonds have E- (trans-) geometry. It has a role as a mouse metabolite, a plant metabolite and a human metabolite. It is a vitamin A and a retinol. — ChEBI
- IUPAC 명칭
- (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
- 분자식
- C20H30O
- 분자량
- 286.5 g/mol
- 정확한 질량
- 286.229665576 Da
- XLogP3
- 5.7
- 위상 극성 표면적
- 20.2 Ų
- 수소 결합 공여체
- 1
- 수소 결합 수용체
- 1
- 공유결합 단위
- 1
- 정의된 입체중심
- 0
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
추가 과학 데이터베이스의 근거
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 279 to 280 °F at 1e-06 mmHg (NTP, 1992) 출처: CAMEO Chemicals
- Boiling Point: 137-138 °C at 1X10-6 mm Hg 출처: Hazardous Substances Data Bank (HSDB)
- Color/Form: Solvated crystals from polar solvents, such as methanol or ethyl formate 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 5.68 출처: DrugBank
- LogP: log Kow = 5.68 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 5.68 출처: Human Metabolome Database (HMDB)
- Melting Point: 144 to 147 °F (NTP, 1992) 출처: CAMEO Chemicals
- Melting Point: 63.5 °C 출처: DrugBank
- Melting Point: 62-64 °C 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: Pale yellow prismatic crystals from methanol; mp: 57-58 °C; UV max (ethanol): 326 nm (E=1,550, 1%, 1 cm) /Retinol acetate/ 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: Amorphous or crystalline; mp: 28-29 °C; UV max (ethanol); 325-328 nm (E=975, 1%, 1 cm) /Retinol palmitate/ 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: 61 - 63 °C 출처: Human Metabolome Database (HMDB)
- Physical Description: Vitamin a appears as yellow crystals or orange solid. Practically water insoluble. (NTP, 1992) 출처: CAMEO Chemicals
- Physical Description: Solid; [Merck Index] Yellow or orange solid; [NTP] 출처: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Physical Description: Solid 출처: Human Metabolome Database (HMDB)
- Refractive Index: Index of refraction: 1.6410 at 20 °C/D (calculated form refractive indexes of 20-70% solutions in mineral oil); max absorption: 324-325 nm (E=1,835, 1%, 1 cm) 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Practically insoluble (NTP, 1992) 출처: CAMEO Chemicals
- Solubility: 0.671 mg/L 출처: DrugBank
- Solubility: Practically insoluble in water or glycerol; soluble in absolute alcohol, methanol, chloroform, ether, fats and oils 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Sol in ethanol and acetone and benzene 출처: Hazardous Substances Data Bank (HSDB)
- Vapor Pressure: 0.00000008 [mmHg] 출처: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Vapor Pressure: 7.5X10-8 mm Hg at 25 °C /Estimated/ 출처: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 출처: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral, readily absorbed from the normal gastrointestinal tract 출처: Toxin and Toxin Target Database (T3DB)
- First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not availabl 출처: CAMEO Chemicals
- Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 311) of reports. 출처: European Chemicals Agency (ECHA)
- Signal: Danger 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (15.8%): Harmful if swallowed [Warning Acute toxicity, oral]; H317 (74.9%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (75.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360 (88.1%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H413 (74.9%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P318, P321, P330, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 311 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 311 reports by companies.; There are 13 notifications provided by 310 of 311 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
- Note: This chemical does not meet GHS hazard criteria for 1% (1 of 105) of reports. 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H317 (99%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (99%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360D (99%): May damage the unborn child [Danger Reproductive toxicity] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P318, P321, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 105 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 105 reports by companies.; There is 1 notification provided by 104 of 105 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
- Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org 출처: Cosmetic Ingredient Review (CIR)
- Toxicity Summary: Signs and Symptoms of Overdose; Vitamin A toxicity may present with various clinical symptoms, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often include mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum retinol levels. Although the diagnosis is primarily clinical, laboratory tests such as serum retinol or retinyl ester levels can assist in confirming the diagnosis. A thorough dietary history is essential to identify excessive vitamin A intake.; Management of Overdose; Symptoms of toxicity may resolve within several weeks after discontinuing vitamin A and initiating supportive therapy. Patients with increased intracranial pressure may require lumbar punctures or medications such as mannitol and diuretics for management. Patients with hypercalcemia may need intravenous fluids and additional treatments, such as calcitonin and corticosteroids. Vitamin A toxicity can present with a range of clinical features, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often show mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum 출처: StatPearls
- Toxicity Summary: Vision:Vitamin A (all-trans retinol) is converted in the retina to the 11-cis-isomer of retinaldehyde or 11-cis-retinal. 11-cis-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-cis-retinal, while attached to opsin in rhodopsin is isomerized to all-trans-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-trans-retinal is then released from opsin and reduced to all-trans-retinol. All-trans-retinol is isomerized to 11-cis-retinol in the dark, and then oxidized to 11-cis-retinal. 11-cis-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-cis retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitami 출처: Toxin and Toxin Target Database (T3DB)
- Cosmetic Ingredient Review Link: CIR ingredient: Retinol 출처: Cosmetic Ingredient Review (CIR)
- Sources/Uses: Essential micronutrient found in animals; [Merck Index] Used as a nutritional supplement for foods; [FDA] Permitted for use as an inert ingredient in non-food pesticide products; [EPA] 출처: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Uses: Vitamin (antixerophthalmic) 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION (VET) 출처: Hazardous Substances Data Bank (HSDB)
- Uses: For the treatment of vitamin A deficiency. Vitamin A helps regulate the immune system, which helps prevent or fight off infections by making white blood cells that destroy harmful bacteria and viruses. 출처: Toxin and Toxin Target Database (T3DB)
매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기
과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.
추가 출처 적용 범위 및 일치 상태
| 출처 | 결과 | 확인됨 |
|---|---|---|
| NIH PubChem PUG-View | 정확히 일치 | 2026-08-31 |
기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

Retinol, acetate
Retinyl acetate is an acetate ester. It is functionally related to an all-trans-retinol. — ChEBI
- IUPAC 명칭
- [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate
- 분자식
- C22H32O2
- 분자량
- 328.5 g/mol
- 정확한 질량
- 328.240230259 Da
- XLogP3
- 6.3
- 위상 극성 표면적
- 26.3 Ų
- 수소 결합 공여체
- 0
- 수소 결합 수용체
- 2
- 공유결합 단위
- 1
- 정의된 입체중심
- 0
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
- ChEBI:CHEBI:32095
- ChEBI:CHEBI:94695
- ChEMBL:CHEMBL486193
- EPA DTXSID:DTXSID6021240
- PubMed:228596
추가 과학 데이터베이스의 근거
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 출처: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 374) of reports. 출처: European Chemicals Agency (ECHA)
- Signal: Danger 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H315 (83.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H360 (59.4%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H361 (39.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H413 (64.4%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P264, P273, P280, P302+P352, P318, P321, P332+P317, P362+P364, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 374 reports by companies from 22 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 374 reports by companies.; There are 21 notifications provided by 373 of 374 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기
과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.
추가 출처 적용 범위 및 일치 상태
| 출처 | 결과 | 확인됨 |
|---|---|---|
| NIH PubChem PUG-View | 정확히 일치 | 2026-08-31 |
기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

Retinol Palmitate
All-trans-retinyl palmitate is an all-trans-retinyl ester obtained by formal condensation of the carboxy group of palmitic (hexadecanoic acid) with the hydroxy group of all-trans-retinol. It is used in cosmetic products to treat various skin disorders such as acne, skin aging, wrinkles, dark spots, and also protect against psoriasis. It has a role as an antioxidant, a human xenobiotic metabolite and an Escherichia coli metabolite. It is a retinyl palmitate and an all-trans-retinyl ester. It is functionally related to an all-trans-retinol. — ChEBI
- IUPAC 명칭
- [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
- 분자식
- C36H60O2
- 분자량
- 524.9 g/mol
- 정확한 질량
- 524.45933115 Da
- XLogP3
- 13.6
- 위상 극성 표면적
- 26.3 Ų
- 수소 결합 공여체
- 0
- 수소 결합 수용체
- 2
- 공유결합 단위
- 1
- 정의된 입체중심
- 0
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
- ChEBI:CHEBI:17616
- ChEMBL:CHEMBL1675
- EPA DTXSID:DTXSID1021241
- PubMed:38191030
- PubMed:32846153
- PubMed:20679000
- PubMed:19686701
- PubMed:17377406
- PubMed:17303254
- PubMed:17299104
- PubMed:17164434
- PubMed:16798117
- PubMed:16741517
- PubMed:16497549
- PubMed:16299098
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.
Retinol; Retinyl Acetate; Retinyl Palmitate의 목록 링크
Retinol; Retinyl Acetate; Retinyl Palmitate의 관련 기록
이 기록에 직접 일치하는 항목이 제한적이어서, 부속서 III의 인접 항목도 함께 표시합니다.
Pinene
Retinol; Retinyl Acetate; Retinyl Palmitate에 대한 부속서 III의 의미
Retinol; Retinyl Acetate; Retinyl Palmitate은(는) EU 화장품 규정 1223/2009 부속서 III에 따른 사용제한 물질입니다. 화장품에서의 사용은 위 항목에 명시된 농도 한도, 제품 유형 제한 및 필수 경고 문구를 포함한 특정 조건에서만 허용됩니다.
이 물질을 처방에 포함할 때는 최대 농도, 제품 범위 및 경고 표시 등 모든 조건을 동시에 충족해야 합니다. 한 조건을 준수한다고 해서 다른 조건이 면제되지 않습니다.
이 기록은 명칭 및 식별자 교차 참조를 위해 CosIng 목록 원료 3건과 연결되어 있습니다. 또한 이 페이지에는 식별자, 부속서 논리 또는 명칭 패턴이 겹치는 관련 부속서 기록 11건이 표시됩니다.
규제 준수 체크리스트
- 처방 농도가 다음을 초과하지 않는지 확인하세요: (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
- 제품 유형 적합성을 확인하세요: (a) Body lotion (b) other leave-on and rinse-off products
- 필수 경고 문구를 제품 표시 사항에 포함하세요.
- 사용 조건을 제품정보파일(PIF)에 기록하세요.
자주 묻는 질문
부속서 III 기록 Retinol; Retinyl Acetate; Retinyl Palmitate의 출처 주석
이 페이지는 공개된 유럽연합 집행위원회 화장품 자료에서 가져온 Retinol; Retinyl Acetate; Retinyl Palmitate의 부속서 III 기록 하나를 요약하고, 가능한 경우 연결된 목록 또는 식별자 일치 항목을 추가합니다.
이 기록 페이지를 이용해 Retinol; Retinyl Acetate; Retinyl Palmitate의 부속서 III 조건을 검토하되, 최종 규제 판단은 현행 공식 부속서 문구 및 원본 파일로 확인하세요.